BioSpace News Archive

Abbott (NYSE: ABT) has been named the Global Industry Leader in sustainability for the seventh consecutive year by the Dow Jones Sustainability Index (DJSI), one of the most prestigious global benchmarks for corporate sustainability.

The U.S. Food and Drug Administration (FDA) has cleared the ARTIS icono, a high-precision family of angiography systems from Siemens Healthineers that permit a wide range of minimally invasive procedures to be performed in a single interventional suite.

Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to advancing medicines for hormone driven cancers, today announced a clinical collaboration with SOLTI, a leading collaborative and academic group in Spain dedicated to clinical and translational research in breast cancer.

Pivot Health Solutions, a leading provider of physical therapy, corporate wellness and occupational health services with two million patient visits in 2018, announced today that various investment funds affiliated with PennantPark Investment Advisers will invest $25 million in the company while existing lenders have reaffirmed their commitment to the business.

Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced that treatment with ACE-083 in patients with facioscapulohumeral muscular dystrophy (FSHD) did not achieve functional secondary endpoints in the Phase 2 trial.

Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today announced that it has retained BND Projects Inc. (“BND”) to provide strategic investor relations services.

Softheon, a national leader in cloud-based health insurance exchange integration, announced today that the Centers for Medicare & Medicaid Services (CMS) approved them as one of the leading Phase 3 Enhanced Direct Enrollment (EDE) vendors.

A simple, quick cure for Alzheimer’s disease will be a “medical miracle”, but will also slash $67 billion of revenue from nursing home operators and assisted living companies, plus cause the loss of 654,000 nursing home jobs, predicts Leslie Norins, M.D., Ph.D., CEO of Alzheimer’s Germ Quest, Inc.

At the 18th Human Proteome Organization World Congress, Bruker announced the release of the diaPASEF workflow, a novel data-independent acquisition method on the timsTOF Pro platform.

Accuray Incorporated announced that, on September 11, 2019, China’s Customs Tariff Commission of the State Council issued a tariff exemption for medical linear accelerators.